Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler - Wikidata - wikimedia - TriplyDB

Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler

Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler

http://www.wikidata.org/entity/Q24562080

about

INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species Treatment of nonalcoholic fatty liver disease: role of AMPK.Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.The chemical uncoupler 2,4-dinitrophenol (DNP) protects against diet-induced obesity and improves energy homeostasis in mice at thermoneutrality Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats.Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents.Mitochondrial dysfunction and insulin resistance: an update.Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice.Weight loss by Ppc-1, a novel small molecule mitochondrial uncoupler derived from slime mold Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes The mitochondrial uncoupler DNP triggers brain cell mTOR signaling network reprogramming and CREB pathway up-regulation Mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone induces vasorelaxation without involving KATP channel activation in smooth muscle cells of arteries Antiinfectives targeting enzymes and the proton motive force.The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis.Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice.Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance.Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance.Targeting adipose tissue in the treatment of obesity-associated diabetes.Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.Combatting type 2 diabetes by turning up the heat.DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya.Regulation of hepatic glucose metabolism in health and disease.Metformin directly acts on mitochondria to alter cellular bioenergetics.Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA).The Multifaceted Roles of Adipose Tissue-Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture.Effects of acute hyperinsulinemia on skeletal muscle mitochondrial function, reactive oxygen species production, and metabolism in premenopausal women.The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice.Mitochondrial-Targeted Catalase Protects Against High-Fat Diet-Induced Muscle Insulin Resistance by Decreasing Intramuscular Lipid Accumulation.In adipose tissue, increased mitochondrial emission of reactive oxygen species is important for short-term high-fat diet-induced insulin resistance in mice.Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice.Fatty acid oxidation is required for active and quiescent brown adipose tissue maintenance and thermogenic programing.Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Pharmacological modulation of mitochondrial calcium homeostasis.Use the Protonmotive Force: Mitochondrial Uncoupling and Reactive Oxygen Species.Deep fried edible oils disturb hepatic redox equilibrium and heightens lipotoxicity and hepatosteatosis in male Wistar rats.

P2860

Q28083473-9FBB1BDA-AC53-4624-A309-3DCF849CA4E3 Q28468438-BAE2BA35-E3D4-4930-95ED-0F3CEDD6BC8B Q30248230-A9D38BD9-9E5B-409F-ACF2-DCAE0A13855C Q33794679-1C048AA5-F556-4952-BA36-B38A04B24749 Q33888483-33AE17B4-5A55-45A6-9CB0-BB2E92E3F651 Q34464742-9D1F0275-B429-4279-BF7D-BD42F69B11F7 Q34533772-7EBC5066-89CF-43D3-B012-357354C0BC69 Q34668089-4C99BAE6-F96D-4962-A86E-A87EE38C8046 Q34988375-E28F1E80-3C12-45BB-AC32-74898567E2BC Q35069125-CB5FC702-6BCD-44BA-8FBE-4774C8DC73D4 Q35130458-881E6FFD-645E-4122-B995-F345AA06E4A3 Q35620205-63761BB4-EB51-4A56-BF4E-A0AAC81A9CBA Q35811523-592C14DF-CFB5-42A1-A75C-FBBD4B5395FC Q35837720-F9E0630F-450D-4BFA-B244-0E1601BAEE7B Q35894095-46234A9B-7DB1-49EB-9403-B844B93996AC Q36106217-6140AA4B-907B-4D42-938E-8D19D6361105 Q36419761-9AEABCBA-8807-480B-A93E-A07681AE8917 Q36430696-BDACA69A-B63F-4554-9FDD-2620010DF5A6 Q37576614-DFD58736-2EC5-4529-A85E-810072FDC103 Q38646388-D7B23588-8906-46E3-9C6F-A6BA92B3A858 Q38672086-0563F572-B722-4342-9C97-A98C7F645BF3 Q38760082-074CD539-6505-4E19-A609-ED43CA3A733F Q38852204-E5284CBB-E334-4966-8083-04FC67114BF4 Q38925481-594DDDD3-9A4A-48C5-B80A-ABD34CEF3F39 Q38945649-12EF55A5-8724-447F-B715-39C063E95B1A Q39418858-56B937C1-320E-4BAD-BDA1-3A515BD4B304 Q39450184-DBF930DB-D035-4108-B5EA-E8482FE69EA5 Q41897802-3D41EA08-2997-4B78-83A5-E51B09EB6F4B Q42127633-2613AA9B-32C7-46D1-B018-A08FB7BFB571 Q42765673-FD3F04AE-F053-4109-BAEF-51C5E40F6BB3 Q46262557-4323B21B-A8AC-4BF5-9E92-BAA26972C4F3 Q46322674-EA5D2118-2197-4108-A348-91BC9B8FC209 Q46370965-3C7F3E91-90A0-467E-9CAF-2E89DDF50E65 Q46762183-569ADCA1-8252-48CE-8940-4D2FD08DFD55 Q47296522-A1F075E7-67BC-4A87-A5D8-C83FFDE03BD2 Q47414585-1CB458E9-10D5-480B-9DE7-F2CE883A5C30 Q47779219-37FDB414-5EAF-400A-AE92-40CBB62EB35F Q48272301-2D7F266E-9E1F-4CCB-AE91-C63709A95BDD Q52329316-E1E74F6D-6579-4791-8958-D06AB69288B1 Q53803400-AA81E490-63EE-4B40-ABB5-2ACDBB06AC39

P2860

Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler

http://www.wikidata.org/entity/Q24562080

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@ast

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@en

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@nl

type

label

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@ast

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@en

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@nl

prefLabel

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@ast

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@en

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@nl

P1433

Q24562080-893BE3FF-EE43-4D2C-823C-94502CC2F79E

P1476

Q24562080-70158ACF-8435-43B0-B911-118263B3289B

P2093

Q24562080-1EE112B0-0F33-4A01-BC3D-A81FD17F275E

Q24562080-1F93BC29-BEDB-44F4-ADAD-434C01DEA25D

Q24562080-800E5FA0-CCB6-4614-A000-23175E73E9D6

Q24562080-86E3C230-705F-4953-AD35-A7E2208136D8

Q24562080-9B643A50-6594-42AC-83C1-2EE0276E269A

Q24562080-B31E5457-6280-4156-A3CE-7408A9E070AE

Q24562080-B8D46191-7423-4E33-82EE-E2F65B3BC99D

Q24562080-C7C83F26-97AF-4FB4-8A1A-0542525F69C7

Q24562080-CA4C4801-B421-4223-BB2B-320C766F6813

P2860

Q24562080-0B5DA957-CF65-4317-91AE-814F258636DF

Q24562080-3293EFC8-46E0-4997-8EB4-656C95A1B11F

Q24562080-3DA125F2-BE44-4A5E-A8EA-A443426EB857

Q24562080-6A0FA49A-DECC-462C-ACD2-50440554D081

Q24562080-7E763671-BB1A-4AA4-BF7B-6141B16DE612

Q24562080-96779DF6-B0AE-4E93-9CB2-EEC36F931E20

Q24562080-98CB4873-6F86-4443-AE3D-D109D33CE4FE

Q24562080-AA9B83A0-AB37-4124-8D5C-B5FB6EB30689

Q24562080-B5B8606C-970C-4C3B-8D59-5C7BA56AF717

Q24562080-B80FBC96-2B45-44AD-8DA5-7AD40F18B4FA

P304

Q24562080-5606CFEC-A098-4C39-8846-69FC23D2D652

P31

Q24562080-38628138-EED0-4F54-AFA2-5C5F7C681680

P356

Q24562080-46189FAE-5A87-4A9B-8496-9B601A7A2434

P407

Q24562080-C2FD8F65-9303-4D03-BD20-C4B1DD641411

P433

Q24562080-D9902FE2-F44F-4E0B-8221-FFEE2CFF810A

P478

Q24562080-4AEFC679-BD54-4FE6-9982-5D73497D3B70

P50

Q24562080-2922A320-25ED-49A8-AC25-503E52A8CD1B

Q24562080-9417A1F2-F14B-4C99-9274-21AE68F11512

Q24562080-E0E47825-951E-4A86-B6F6-69FA70AE4EC0

P577

Q24562080-7D373D6D-8441-4207-9FD3-3099AD138AB8

P5875

Q24562080-0CAEB1E7-AF84-4159-9CED-B64B4BA8BEDF

P698

Q24562080-F2466909-5733-4F88-829D-E162A466D7FA

P921

Q24562080-1E5B60CC-AB6E-4959-A943-E83B273B42B0

Q24562080-277B5463-41FC-40E8-8CF5-360AE1375D85

Q24562080-998411F4-19E7-4C12-AB44-29F1943016B7

P932

Q24562080-986FEDD7-83F4-44D5-8F0C-2C409D264DA2

P356

J.CMET.2013.10.004

P1433

Cell Metabolism

P1476

Reversal of hypertriglyceridem ...... rgeted mitochondrial uncoupler

@en

P2093

David A Spiegel

http://www.w3.org/2001/XMLSchema#string

Dominik Pesta

http://www.w3.org/2001/XMLSchema#string

Dongyan Zhang

http://www.w3.org/2001/XMLSchema#string

Gary W Cline

http://www.w3.org/2001/XMLSchema#string

Rachel J Perry

http://www.w3.org/2001/XMLSchema#string

Taehan Kim

http://www.w3.org/2001/XMLSchema#string

Violeta B Popov

http://www.w3.org/2001/XMLSchema#string

Xian-Man Zhang

http://www.w3.org/2001/XMLSchema#string

Yasmeen Rahimi

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Dinitrophenol in Nutritional Disorders : A Critical Survey of Clinical Results

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

Cellular mechanisms of insulin resistance

Mechanisms for insulin resistance: common threads and missing links

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance.

Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

P304

740-748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2013.10.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Jurczak

Gerald I. Shulman

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258425844

http://www.w3.org/2001/XMLSchema#string

P698

24206666

http://www.w3.org/2001/XMLSchema#string

P921

P932

4104686

http://www.w3.org/2001/XMLSchema#string